Related Experiment Video
Updated: Dec 11, 2025

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Antimicrobial Peptide AMP-17 Affects Candida albicans by Disrupting Its Cell Wall and Cell Membrane Integrity
Huiling Ma1,2, Xinyu Zhao1, Longbing Yang1
1Key and Characteristic Laboratory of Modern Pathogen Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, People's Republic of China.
Background:
Candida albicans is associated with high mortality among immunocompromised patients. Resistance to and toxic side effects of antifungal drugs require the development of alternative antifungal agents. AMP-17 is a novel antimicrobial peptide derived from Musca domestica that exerts excellent antifungal effects against the Candida species. In this article, we discuss the potential mechanism of AMP-17 against C. albicans from the perspective of affecting the latter's cell external structure.
Methods:
Recombinant AMP-17 was prepared by prokaryotic expression system, and its anti-C. albicans activity was detected by microdilution method. Microscopy and scanning electron microscopy were used to examine morphological changes in C. albicans. Cell wall-specific staining method was used to detect the change of cell wall integrity of C. albicans after AMP-17 treatment. AMP-17-induced damage to the C. albicans cell membrane was analyzed by fluorescent probes and glycerol assay kit. The expression of genes related to fungal cell wall and cell-membrane synthesis was detected by qRT-PCR.
Results:
Morphological observations showed that the growth of C. albicans was significantly inhibited in AMP-17-treated cells; the cells appeared aggregated and dissolved, with severe irregularities in shape. Furthermore, AMP-17 damaged the integrity of C. albicans cell walls. The cell wall integrity rate of AMP-17-treated cells was only 21.7% compared to untreated cells. Moreover, the change of membrane dynamics and permeability suggested that the cell membrane was disrupted by AMP-17 treatment. Genetic analysis showed that after AMP-17 treatment, the cell wall synthesis-related gene FKS2 of C. albicans was up-regulated 3.46-fold, while the cell membrane ergosterol synthesis-related genes ERG1, ERG5, ERG6, and MET6 were down-regulated 5.88-, 17.54-, 13.33-, and 7.14-fold, respectively.
Conclusion:
AMP-17 treatment disrupted the cell wall integrity and membrane structure of C. albicans and is likely a novel therapeutic option for prevention and control of C. albicans infections.
Insights
AMP-17, an antimicrobial peptide, disrupts Candida albicans cell walls and membranes, offering a potential new treatment for infections. This peptide shows promise in combating drug-resistant fungal infections.
Area of Science:
- Mycology
- Antimicrobial Peptides
- Biochemistry
Background:
- Candida albicans poses a significant mortality risk to immunocompromised individuals.
- Antifungal drug resistance and toxicity necessitate novel therapeutic agents.
- AMP-17, a peptide from Musca domestica, demonstrates potent antifungal activity against Candida species.
Purpose of the Study:
- To investigate the mechanism of AMP-17 against Candida albicans.
- To analyze AMP-17's effects on the external cell structure of C. albicans.
- To evaluate AMP-17 as a potential antifungal agent.
Main Methods:
- Recombinant AMP-17 was produced and its antifungal activity assessed via microdilution.
- Microscopy, including scanning electron microscopy, was used to observe morphological changes.
- Cell wall integrity, membrane permeability, and gene expression related to cell wall and membrane synthesis were analyzed.
Main Results:
- AMP-17 significantly inhibited C. albicans growth, causing cell aggregation and morphological irregularities.
- AMP-17 treatment reduced cell wall integrity to 21.7% and disrupted cell membrane permeability.
- Gene expression analysis revealed upregulation of FKS2 and downregulation of ERG1, ERG5, ERG6, and MET6.
Conclusions:
- AMP-17 effectively disrupts the cell wall integrity and membrane structure of Candida albicans.
- AMP-17 represents a promising novel therapeutic option for managing C. albicans infections.
- Further research into AMP-17's mechanism and efficacy is warranted.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Cell Wall
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness

